<DOC>
	<DOCNO>NCT02913118</DOCNO>
	<brief_summary>Adjunctive Therapy AndrographolidSulfonate Community Acquired Pneumonia : A Multicenter , Randomized , Double-blinded , Placebo Controlled Clinical Trial . The hypothesis combination therapy Andrographolid Sulfonatein injection antibacterial significantly well antibacterial alone achieve clinical stability among hospitalized CAP patient .</brief_summary>
	<brief_title>Adjunctive Therapy Andrographolid Sulfonatein Community Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Age 1875 year , gender restriction . Voluntary participation , participant provide write informed consent . Volunteers hospitalize patient Patients hospitalize community acquire pneumonia T≥38°C within 24 hour enrol Diagnosis CAP ( Chinese Guideline Diagnosis Management Community Acquired Pneumonia Adults 2016 ) 1 . Pneumonia acquire community 2 . Symptoms sign pneumonia : 1 . Presence cough , expectoration exacerbation chronic airway disease , without purulent sputum/chest pain/dyspnea/hemoptysis . 2 . Presence offever . 3 . Lung consolidation and/or moist rale . 4 . Peripheral blood（WBC） &gt; 10×109/L &lt; 4×109/L , without nuclear left shift ; 3 . Chest radiograph show new groundglass opacity , patchy infiltration , consolidation interstitial change , without pleural effusion . Patients meet 1,3 one item 2 , exclude one follow clinically classified CAP : pulmonary tuberculosis , cancer , noninfectious interstitial lung disease , pulmonary edema , atelectasis , pulmonary embolism , pulmonary eosinophilia pulmonary vasculitis . CURB 65≥1 point , Each risk factor score one point , maximum score 5 : Confusion new onset Blood Urea nitrogen great 7 mmol/l ( 19 mg/dL ) Respiratory rate 30 breath per minute great Blood pressure le 90 mmHg systolic diastolic blood pressure 60 mmHg less Age 65 old Within 72 hour symptom onset Known allergy AS Pregnant breastfeed Heart dysfunction , NYHA IIIIV class Hematological system disease , lymphoma , leukemia , agranulocytosis ( neutrophil count &lt; 0.5×109/L ) . Autoimmune diseases disease active Terminal malignant tumor Longterm treatment high dose corticosteroid ( prednisone 10mg/d ≥2 week ) immunosuppressive agent Inflammatory bowel disease , Crohn 's disease , ulcerative colitis Chronic renal failure , eGFR &lt; 50 ml/min/1.73m2 Severe liver function damage , ALT AST great equal 2 time upper limit normal Hypernatremia , serum sodium≥145mmol/L Diagnosis severe pneumonia : Diagnostic criterion severe pneumonia : patient meet one major criterion least 3 minor criterion classify severe case : Major criterion : ①the need invasive mechanical ventilation②sepsis shock active fluid resuscitation still need vasoactive drug ; Minor criterion : ①respiratory rate &gt; 30 breaths/min , ②PaO2/FiO2≤250mmHg（1mmHg=0.133kPa） , ③multilobar infiltrates , ④confusion or/andunorientation , ⑤bloodurea nitrogen level≥20mg/dl（7.14mmol/L） , ⑥systolic pressure ＜90mmHg need active fluid resuscitation Defervescence use corticosteroid symptom onset . Patients participate another intervention study within month Other condition suitable inclusion accord investigator ' judgment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>